The images for [S2](#pone.0146631.s001){ref-type="supplementary-material"}, [S3](#pone.0146631.s002){ref-type="supplementary-material"} and [S4](#pone.0146631.s003){ref-type="supplementary-material"} Figs are incorrect. Please view the correct [S2](#pone.0146631.s001){ref-type="supplementary-material"}, [S3](#pone.0146631.s002){ref-type="supplementary-material"} and [S4](#pone.0146631.s003){ref-type="supplementary-material"} Figs here.

Supporting Information {#sec001}
======================

###### Representative immunohistochemistry analyses to determine the induction of total IgG in the spleen sections of the vaccinated animals after three weeks and six months post the final immunisation, oE2 plus Quil A (a) and (b); FD oE2 plus Quil A (c) and (d); oE2/SV-140 (e) and (f); FD oE2/SV-140 (g) and (h); FD SV-140 (i) and (j); unimmnised (k) and (l).
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###### 

Click here for additional data file.

###### 

Histopathology studies of tissue organs from a mouse injected with nanovaccine immunisations; A) Three weeks post the final immunisation, organs fixed in formalin were harvested from two mice for each treatment group and embedded in paraffin, sections were stained with hematoxylin and eosin stain. i) Heart, ii) Injection sites, iii) Kidney, iv) Liver. B) Six months post the final immunisation, organs fixed in formalin were harvested from two mice for each treatment group and embedded in paraffin, sections were stained with hematoxylin and eosin stain. i) Heart, ii) Injection sites, iii) Kidney, iv) Liver.
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###### 

Click here for additional data file.

###### End point titer data of terminal sera bleeds.

All the mice were administered 100 μL of two vaccine doses at 3 week intervals at the tail base. Group 1 (mouse 1 to 8) received 100 μg oE2 plus 10 μg Quil-A; Group 2 (mouse 1 to 8) received the FD 100 μg oE2 plus 10 μg Quil-A, Group 3 (mouse 1 to 8) received the oE2 nanovaccine (100 μg oE2 adsorbed to 500 μg SV-140), Group 4 (mouse 1 to 8) received the FD oE2 nanovaccine (100 μg oE2 adsorbed to 500 μg SV-140), Group 5 (mouse 1 to 8) received the FD 500 μg SV-140, Group 6 (mouse 1 to 8) was the unimmunised group and did not receive any vaccination. Sera of individual animals were diluted from 1:100 to 1:6400.
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Click here for additional data file.
